Recombinant Mouse Vasorin/SLIT-like 2 Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 8948-VN
Key Product Details
Product Specifications
Source
Mouse myeloma cell line, NS0-derived mouse Vasorin/SLIT-like 2 protein
Cys25-Pro576, with a C-terminal 6-His tag
Cys25-Pro576, with a C-terminal 6-His tag
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Cys25
Predicted Molecular Mass
61 kDa
SDS-PAGE
72-97 kDa, reducing conditions
Activity
Measured by its binding ability in a functional ELISA.
When Recombinant Mouse TGF- beta2 (Catalog # 7346-B2) is immobilized at 1 µg/mL (100 µL/well), the concentration of Recombinant Mouse Vasorin/SLIT-like 2 that produces 50% of the optimal binding response is approximately 0.3-1.8 μg/mL
When Recombinant Mouse TGF- beta2 (Catalog # 7346-B2) is immobilized at 1 µg/mL (100 µL/well), the concentration of Recombinant Mouse Vasorin/SLIT-like 2 that produces 50% of the optimal binding response is approximately 0.3-1.8 μg/mL
Formulation, Preparation and Storage
8948-VN
Formulation | Lyophilized from a 0.2 μm filtered solution in MOPS, NaCl, Ethylene Glycol and Trehalose. |
Reconstitution |
Reconstitute at 250 μg/mL in water.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage |
Background: Vasorin/SLIT-like 2
References
- Ikeda, Y. et al. (2004) Proc. Natl. Acad. Sci. USA 101:10732.
- Krautzberger, A.M. et al. (2012) Gene Expr. Patterns 12:167.
- Malapeira, J. et al. (2011) Oncogene 30:1912.
- Li, S. et al. (2015) Oncotarget 6:10045.
Alternate Names
Atia, SLIT like 2, Slitl2, VASN
Gene Symbol
VASN
UniProt
Additional Vasorin/SLIT-like 2 Products
Product Documents for Recombinant Mouse Vasorin/SLIT-like 2 Protein, CF
Product Specific Notices for Recombinant Mouse Vasorin/SLIT-like 2 Protein, CF
For research use only
Loading...
Loading...
Loading...